82 related articles for article (PubMed ID: 297386)
1. Effects of therapy on vitreous fluorophotometry in diabetes mellitus.
Waltman SR; Krupin T; Singer P; Becker B
Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):8-9. PubMed ID: 297386
[TBL] [Abstract][Full Text] [Related]
2. Vitreous fluorophotometry in adult-onset diabetes mellitus.
Waltman SR; Krupin T; Kilo C; Becker B
Am J Ophthalmol; 1979 Sep; 88(3 Pt 1):342-5. PubMed ID: 484662
[TBL] [Abstract][Full Text] [Related]
3. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
[TBL] [Abstract][Full Text] [Related]
4. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
5. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
Bordat B; Guirgis IR; Manderscheid JC
J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
[TBL] [Abstract][Full Text] [Related]
6. Vitreous fluorophotometry in juvenile diabetes.
Kernell A; Larsson Y; Ludvigsson J; Tenland T
Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
[TBL] [Abstract][Full Text] [Related]
7. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
[TBL] [Abstract][Full Text] [Related]
8. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
Waltman SR
Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
[TBL] [Abstract][Full Text] [Related]
9. [Early diagnosis of diabetic retinopathy in patients with diabetes type I, using vitreous fluorophotometry].
Janiec S; Sośnierz-Jupowiecka A; Rzendkowski M
Klin Oczna; 1994; 96(8-9):265-7. PubMed ID: 7897991
[TBL] [Abstract][Full Text] [Related]
10. [The influence of retinal argon laser photocoagulation on results of vitreous fluorophotometry in patients with diabetic retinopathy].
Gierek-Lapińska A; Formińska-Kapuścik M; Janiec S; Rzendkowski M
Klin Oczna; 1994; 96(8-9):263-4. PubMed ID: 7897990
[TBL] [Abstract][Full Text] [Related]
11. Vitreous fluorophotometric evaluation of diabetics.
Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
[TBL] [Abstract][Full Text] [Related]
12. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
Krupin T; Waltman SR
Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
[TBL] [Abstract][Full Text] [Related]
13. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M
Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
[TBL] [Abstract][Full Text] [Related]
14. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
[TBL] [Abstract][Full Text] [Related]
16. [Structural and functional disorders of transcapillary metabolism if retina in patients with diabetic retinopathy].
Sorokin EL; Smoliakova GP
Vestn Oftalmol; 1997; 113(2):16-9. PubMed ID: 9229896
[TBL] [Abstract][Full Text] [Related]
17. Ocular fluorophotometry in diabetic patients without apparent retinopathy.
Kayazawa F
Ann Ophthalmol; 1984 Mar; 16(3):221-5. PubMed ID: 6712065
[TBL] [Abstract][Full Text] [Related]
18. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
[TBL] [Abstract][Full Text] [Related]
19. [Fluorophotometry of the vitreous body in insulin-dependent diabetes mellitus with minimal retinopathy or without it].
Roy MS; Podgor MJ; Grunberger G; Carl J; Bungay P; Ellis D
Ophtalmologie; 1987; 1(2):151-4. PubMed ID: 3153837
[No Abstract] [Full Text] [Related]
20. Blood-retinal barriers in health and disease.
Cunha-Vaz JG
Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):337-40. PubMed ID: 6946626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
